Cannasouth Ltd Ordinary Shares CBD
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- NZD 0.10
- Day Range
- NZD 0.10–0.10
- 52-Week Range
- NZD 0.10–0.31
- Bid/Ask
- NZD 0.00 / NZD 0.00
- Market Cap
- NZD 32.39 Mil
- Volume/Avg
- 204,091 / 115,540
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 25.65
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Cannasouth Ltd is a New Zealand based company involved in the medicinal cannabis sector. Its focus is to research the benefits of medicinal cannabis and to develop a range of medicinal cannabis-related products for distribution in New Zealand and globally. The company operates in single segment: the biopharmaceutics market i.e., the production and supply (including research and development) of biopharmaceuticals, specializing in cannabinoid medicines; with the area of operation being New Zealand.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Growth
- Total Number of Employees
- 11
- Website
- https://www.cannasouth.co.nz
Valuation
|
Metric
|
CBD
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 0.67 |
Price/Sales | 25.65 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
CBD
|
|---|---|
Quick Ratio | 1.81 |
Current Ratio | 2.27 |
Interest Coverage | −45.09 |
Quick Ratio
CBD
Profitability
|
Metric
|
CBD
|
|---|---|
Return on Assets (Normalized) | −22.06% |
Return on Equity (Normalized) | −27.37% |
Return on Invested Capital (Normalized) | −23.15% |
Return on Assets
CBD
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Nvmsmfhvl | Wcfnq | $70.0 Bil | |
MKKGY
| Merck KGaA ADR | Ysvrmlkbdt | Yvxmllq | $68.1 Bil | |
HLN
| Haleon PLC ADR | Mxbwsnwn | Zkz | $36.5 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Msbhgrdmh | Zrss | $14.3 Bil | |
VTRS
| Viatris Inc | Qbrhmrs | Dxnzp | $13.2 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Mjrcjjxz | Csn | $11.9 Bil | |
CTLT
| Catalent Inc | Qwltffks | Tqdwzm | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Swbycjyr | Bnpj | $4.1 Bil | |
CURLF
| Curaleaf Holdings Inc | Tgrsnjqt | Wgrl | $3.7 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Yfcxwyfym | Kqdwlpm | $3.4 Bil |